Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 540451, 13 pages
http://dx.doi.org/10.1155/2014/540451
Review Article

Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics

Applied Molecular Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India

Received 29 January 2014; Accepted 18 March 2014; Published 22 June 2014

Academic Editor: Gary S. Stein

Copyright © 2014 Baby Santosh and Pramod K. Yadava. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. D. Ellington and J. W. Szostak, “In vitro selection of RNA molecules that bind specific ligands,” Nature, vol. 346, no. 6287, pp. 818–822, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Tuerk and L. Gold, “Systemic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase,” Science, vol. 249, no. 4968, pp. 505–510, 1990. View at Publisher · View at Google Scholar · View at Scopus
  3. D. H. J. Bunka and P. G. Stockley, “Aptamers come of age—at last,” Nature Reviews Microbiology, vol. 4, no. 8, pp. 588–596, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Stoltenburg, C. Reinemann, and B. Strehlitz, “SELEX—a (r)evolutionary method to generate high-affinity nucleic acid ligands,” Biomolecular Engineering, vol. 24, no. 4, pp. 381–403, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Hermann and D. J. Patel, “Adaptive recognition by nucleic acid aptamers,” Science, vol. 287, no. 5454, pp. 820–825, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Gold, “Oligonucleotides as research, diagnostic, and therapeutic agents,” The Journal of Biological Chemistry, vol. 270, no. 23, pp. 13581–13584, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Pollard, S. D. Bell, and A. D. Ellington, “Design, synthesis, and amplification of DNA pools for in vitro selection,” in Current Protocols in Nucleic Acid Chemistry, John Wiley & Sons, Chapter 9, Unit 9.2 edition, 2001. View at Google Scholar
  8. A. V. Kulbachinskiy, “Methods for selection of aptamers to protein targets,” Biochemistry, vol. 72, no. 13, pp. 1505–1518, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Yang, D. Yang, H. J. Schluesener, and Z. Zhang, “Advances in SELEX and application of aptamers in the central nervous system,” Biomolecular Engineering, vol. 24, no. 6, pp. 583–592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S.-Y. Hwang, H.-Y. Sun, K.-H. Lee et al., “5′-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity,” Nucleic Acids Research, vol. 40, no. 6, pp. 2724–2733, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. J. Lee and S.-W. Lee, “Regression of hepatocarcinoma cells using RNA aptamer specific to alpha-fetoprotein,” Biochemical and Biophysical Research Communications, vol. 417, no. 1, pp. 521–527, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Bala, A. Bhaskar, A. Varshney, A. K. Singh, S. Dey, and P. Yadava, “In vitro selected RNA aptamer recognizing glutathione induces ROS-mediated apoptosis in the human breast cancer cell line MCF 7,” RNA Biology, vol. 8, no. 1, pp. 101–111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. U. Brockstedt, A. Uzarowska, A. Montpetit, W. Pfau, and D. Labuda, “In vitro evolution of RNA aptamers recognizing carcinogenic aromatic amines,” Biochemical and Biophysical Research Communications, vol. 313, no. 4, pp. 1004–1008, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Xu and A. D. Ellington, “Anti-peptide aptamers recognize amino acid sequence and bind a protein epitope,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 15, pp. 7475–7480, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. T. M. A. Gronewold, A. Baumgartner, J. Hierer et al., “Kinetic binding analysis of aptamers targeting HIV-1 proteins by a combination of a Microbalance Array and Mass Spectrometry (MAMS),” Journal of Proteome Research, vol. 8, no. 7, pp. 3568–3577, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Zhou, H. Li, S. Li, J. Zaia, and J. J. Rossi, “Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy,” Molecular Therapy, vol. 16, no. 8, pp. 1481–1489, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Ulrich, J. E. Ippolito, O. R. Pagán et al., “In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 24, pp. 14051–14056, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Rentmeister, A. Bill, T. Wahle, J. Walter, and M. Famulok, “RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of β-secretase BACE1 in vitro,” RNA, vol. 12, no. 9, pp. 1650–1660, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Li, H. H. Nguyen, M. Byrom, and A. D. Ellington, “Inhibition of cell proliferation by an anti-EGFR aptamer,” PLoS ONE, vol. 6, no. 6, Article ID e20299, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Barfod, T. Persson, and J. Lindh, “In vitro selection of RNA aptamers against a conserved region of the Plasmodium falciparum erythrocyte membrane protein 1,” Parasitology Research, vol. 105, no. 6, pp. 1557–1566, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. N. C. Pagratis, C. Bell, Y. F. Chang et al., “Potent 2′-amino-, and 2′-fluoro-2′-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor,” Nature Biotechnology, vol. 15, no. 1, pp. 68–73, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. D. O'Codnnell, A. Koenig, S. Jennings et al., “Calcium-dependent oligonucleotide antagonists specific for L-selectin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 12, pp. 5883–5887, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. D.-B. Huang, D. Vu, L. A. Cassiday, J. M. Zimmerman, L. J. Maher III, and G. Ghosh, “Crystal structure of NF-κB (p50)2 complexed to a high-affinity RNA aptamer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 16, pp. 9268–9273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. J. O. McNamara II, E. R. Andrechek, Y. Wang et al., “Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras,” Nature Biotechnology, vol. 24, no. 8, pp. 1005–1015, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. S. K. Lee, M. W. Park, E. G. Yang, J. Yu, and S. Jeong, “An RNA aptamer that binds to the β-catenin interaction domain of TCF-1 protein,” Biochemical and Biophysical Research Communications, vol. 327, no. 1, pp. 294–299, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. B. J. Hicke, C. Marion, Y. F. Chang et al., “Tenascin-C aptamers are generated using tumor cells and purified protein,” The Journal of Biological Chemistry, vol. 276, no. 52, pp. 48644–48654, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. B. J. Hicke, A. W. Stephens, T. Gould et al., “Tumor targeting by an aptamer,” Journal of Nuclear Medicine, vol. 47, no. 4, pp. 668–678, 2006. View at Google Scholar · View at Scopus
  28. S. P. Ohuchi, T. Ohtsu, and Y. Nakamura, “Selection of RNA aptamers against recombinant transforming growth factor-β type III receptor displayed on cell surface,” Biochimie, vol. 88, no. 7, pp. 897–904, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-H. Lee, M. D. Canny, A. De Erkenez et al., “A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 52, pp. 18902–18907, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Bardeesy and J. Pelletier, “Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product,” Nucleic Acids Research, vol. 26, no. 7, pp. 1784–1792, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. H. K. Lee, Y. S. Choi, Y. A. Park, and S. Jeong, “Modulation of oncogenic transcription and alternative splicing by β-catenin and an RNA aptamer in colon cancer cells,” Cancer Research, vol. 66, no. 21, pp. 10560–10566, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. B. A. Gilbert, M. Sha, S. T. Wathen, and R. R. Rando, “RNA aptamers that specifically bind to a K ras-derived farnesylated peptide,” Bioorganic & Medicinal Chemistry, vol. 5, no. 6, pp. 1115–1122, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Ylera, R. Lurz, V. A. Erdmann, and J. P. Fürste, “Selection of RNA aptamers to the alzheimer's disease amyloid peptide,” Biochemical and Biophysical Research Communications, vol. 290, no. 5, pp. 1583–1588, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Li, H. Xu, H. Ding et al., “Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX,” The Journal of Pathology, vol. 218, no. 3, pp. 327–336, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Liu, J.-H. Duan, Y.-M. Song et al., “Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro,” Journal of Translational Medicine, vol. 10, no. 1, article 148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. S. R. Han and S.-W. Lee, “In vitro selection of RNA aptamer specific to salmonella typhimurium,” Journal of Microbiology and Biotechnology, vol. 23, no. 6, pp. 878–884, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. M. B. Murphy, S. T. Fuller, P. M. Richardson, and S. A. Doyle, “An improved method for the in vitro evolution of aptamers and applications in protein detection and purification,” Nucleic Acids Research, vol. 31, no. 18, article e110, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Song, Z. Zhu, Y. An et al., “Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture,” Analytical Chemistry, vol. 85, no. 8, pp. 4141–4149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. C. S. M. Ferreira, C. S. Matthews, and S. Missailidis, “DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers,” Tumor Biology, vol. 27, no. 6, pp. 289–301, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Slupianek, Y. Dasgupta, S.-Y. Ren et al., “Targeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia,” Blood, vol. 118, no. 4, pp. 1062–1068, 2011. View at Google Scholar
  41. A.-L. Rérole, J. Gobbo, A. De Thonel et al., “Peptides and aptamers targeting HSP70: a novel approach for anticancer chemotherapy,” Cancer Research, vol. 71, no. 2, pp. 484–495, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Butz, C. Denk, A. Ullmann, M. Scheffner, and F. Hoppe-Seyler, “Induction of apoptosis in human papillomavirus-positive cancer cells by peptide aptamers targeting the viral E6 oncoprotein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 12, pp. 6693–6697, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Kunz, C. Borghouts, C. Buerger, and B. Groner, “Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to taxol,” Molecular Cancer Research, vol. 4, no. 12, pp. 983–986, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. F. C. Richardson, B. C. Tennant, D. J. Meyer et al., “An evaluation of the toxicities of 2′-fluorouridine and 2′- fluorocytidine-HCl in F344 rats and woodchucks (Marmota monax),” Toxicologic Pathology, vol. 27, no. 6, pp. 607–617, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. P. S. Shannon Pendergrast, H. N. Nicholas Marsh, D. Grate, J. M. Healy, and M. Stanton, “Nucleic acid aptamers for target validation and therapeutic applications,” Journal of Biomolecular Techniques, vol. 16, no. 3, pp. 224–234, 2005. View at Google Scholar · View at Scopus
  46. C. E. Tucker, L. Chen, M. B. Judkins, J. A. Farmer, S. C. Gill, and D. W. Drolet, “Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys,” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 732, no. 1, pp. 203–212, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Lin, Q. Qiu, S. C. Gill, and S. D. Jayasena, “Modified RNA sequence pools for in vitro selection,” Nucleic Acids Research, vol. 22, no. 24, pp. 5229–5234, 1994. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Reyderman and S. Stavchansky, “Pharmacokinetics and biodistribution of a nucleotide-based thrombin inhibitor in rats,” Pharmaceutical Research, vol. 15, no. 6, pp. 904–910, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. D. J. Stickler, J. B. King, C. Winters, and S. L. Morris, “Blockage of urethral catheters by bacterial biofilms,” Journal of Infection, vol. 27, no. 2, pp. 133–135, 1993. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Savory, D. Lednor, K. Tsukakoshi et al., “In silico maturation of binding-specificity of DNA aptamers against Proteus mirabilis,” Biotechnology and Bioengineering, vol. 110, no. 10, pp. 2573–2580, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. F. Pastor, M. M. Soldevilla, H. Villanueva et al., “CD28 aptamers as powerful immune response modulators,” Molecular Therapy—Nucleic Acids, vol. 2, article e98, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. W. C. Winkler and R. R. Breaker, “Regulation of bacterial gene expression by riboswitches,” Annual Review of Microbiology, vol. 59, pp. 487–517, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. B. J. Tucker and R. R. Breaker, “Riboswitches as versatile gene control elements,” Current Opinion in Structural Biology, vol. 15, no. 3, pp. 342–348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Matylla-Kulinska, J. L. Boots, B. Zimmermann, and R. Schroeder, “Finding aptamers and small ribozymes in unexpected places,” Wiley Interdisciplinary Reviews: RNA, vol. 3, no. 1, pp. 73–91, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. R. K. Montange and R. T. Batey, “Riboswitches: emerging themes in RNA structure and function,” Annual Review of Biophysics, vol. 37, pp. 117–133, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. Wan, Y. Kim, N. Li et al., “Surface-immobilized aptamers for cancer cell isolation and microscopic cytology,” Cancer Research, vol. 70, no. 22, pp. 9371–9380, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Zhang, N. Zhao, Z. Zeng et al., “Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells,” Laboratory Investigation, vol. 89, no. 12, pp. 1423–1432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. S. L. Stead, H. Ashwin, B. Johnston et al., “An RNA-aptamer-based assay for the detection and analysis of malachite green and leucomalachite green residues in fish tissue,” Analytical Chemistry, vol. 82, no. 7, pp. 2652–2660, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Flinders, S. C. DeFina, D. M. Brackett, C. Baugh, C. Wilson, and T. Dieckmann, “Recognition of planar and nonplanar ligands in the malachite green—RNA aptamer complex,” ChemBioChem, vol. 5, no. 1, pp. 62–72, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Dua, S. Kim, and D.-K. Lee, “Nucleic acid aptamers targeting cell-surface proteins,” Methods, vol. 54, no. 2, pp. 215–225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. D. Shangguan, Z. Cao, L. Meng et al., “Cell-specific aptamer probes for membrane protein elucidation in cancer cells,” Journal of Proteome Research, vol. 7, no. 5, pp. 2133–2139, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Li, H. J. Lee, and R. M. Corn, “Detection of protein biomarkers using RNA aptamer microarrays and enzymatically amplified surface plasmon resonance imaging,” Analytical Chemistry, vol. 79, no. 3, pp. 1082–1088, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. L. H. Lauridsen and R. N. Veedu, “Nucleic acid aptamers against biotoxins: a new paradigm toward the treatment and diagnostic approach,” Nucleic Acid Therapeutics, vol. 22, no. 6, pp. 371–379, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. J. B.-H. Tok and N. O. Fischer, “Single microbead SELEX for efficient ssDNA aptamer generation against botulinum neurotoxin,” Chemical Communications, no. 16, pp. 1883–1885, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. J. G. Bruno and J. L. Kiel, “Use of magnetic beads in selection and detection of biotoxin aptamers by electrochemiluminescence and enzymatic methods,” BioTechniques, vol. 32, no. 1, pp. 178–183, 2002. View at Google Scholar · View at Scopus
  66. J. R. Hesselberth, D. Miller, J. Robertus, and A. D. Ellington, “In vitro selection of RNA molecules that inhibit the activity of ricin A-chain,” Journal of Biological Chemistry, vol. 275, no. 7, pp. 4937–4942, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. E. A. Lamont, L. He, K. Warriner, T. P. Labuza, and S. Sreevatsan, “A single DNA aptamer functions as a biosensor for ricin,” Analyst, vol. 136, no. 19, pp. 3884–3895, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. J. G. Bruno and J. L. Kiel, “In vitro selection of DNA aptamers to anthrax spores with electrochemiluminescence detection,” Biosensors and Bioelectronics, vol. 14, no. 5, pp. 457–464, 1999. View at Publisher · View at Google Scholar · View at Scopus
  69. M. N. Win, J. S. Klein, and C. D. Smolke, “Codeine-binding RNA aptamers and rapid determination of their binding constants using a direct coupling surface plasmon resonance assay,” Nucleic Acids Research, vol. 34, no. 19, pp. 5670–5682, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. G. Pothoulakis, F. Ceroni, B. Reeve, and T. Ellis, “The Spinach RNA Aptamer as a characterization tool for synthetic biology,” ACS Synthetic Biology, vol. 3, no. 3, pp. 182–187, 2014. View at Publisher · View at Google Scholar
  71. A. D. Kent, N. G. Spiropulos, and J. M. Heemstra, “General approach for engineering small-molecule-binding DNA split aptamers,” Analytical Chemistry, vol. 85, no. 20, pp. 9916–9923, 2013. View at Publisher · View at Google Scholar
  72. T. G. McCauley, N. Hamaguchi, and M. Stanton, “Aptamer-based biosensor arrays for detection and quantification of biological macromolecules,” Analytical Biochemistry, vol. 319, no. 2, pp. 244–250, 2003. View at Publisher · View at Google Scholar · View at Scopus
  73. K. M. Thompson, H. A. Syrett, S. M. Knudsen, and A. D. Ellington, “Group I aptazymes as genetic regulatory switches,” BMC Biotechnology, vol. 2, article 21, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Hanson, K. Berthelot, B. Fink, J. E. G. McCarthy, and B. Suess, “Tetracycline-aptamer-mediated translational regulation in yeast,” Molecular Microbiology, vol. 49, no. 6, pp. 1627–1637, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Jeong, H. K. Lee, and M. Y. Kim, “Use of RNA aptamers for the modulation of cancer cell signaling,” Methods in Molecular Biology, vol. 542, pp. 363–377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Sivanesan, M. D. Howell, C. J. Didonato, and R. N. Singh, “Antisense oligonucleotide mediated therapy of spinal muscular atrophy,” Translational Neuroscience, vol. 4, no. 1, pp. 1–7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. B. Soontornworajit and Y. Wang, “Nucleic acid aptamers for clinical diagnosis: cell detection and molecular imaging,” Analytical and Bioanalytical Chemistry, vol. 399, no. 4, pp. 1591–1599, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. S. D. Jayasena, “Aptamers: an emerging class of molecules that rival antibodies in diagnostics,” Clinical Chemistry, vol. 45, no. 9, pp. 1628–1650, 1999. View at Google Scholar · View at Scopus
  79. K. Germer, M. Leonard, and X. Zhang, “RNA aptamers and their therapeutic and diagnostic applications,” International Journal of Biochemistry and Molecular Biology, vol. 4, no. 1, pp. 27–40, 2013. View at Google Scholar · View at Scopus
  80. E. W. M. Ng, D. T. Shima, P. Calias, E. T. Cunningham Jr., D. R. Guyer, and A. P. Adamis, “Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease,” Nature Reviews Drug Discovery, vol. 5, no. 2, pp. 123–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. F. Mongelard and P. Bouvet, “AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia,” Current Opinion in Molecular Therapeutics, vol. 12, no. 1, pp. 107–114, 2010. View at Google Scholar · View at Scopus
  82. G. Sinha, “Regado's aptamer lines up against anticoagulants,” Nature Biotechnology, vol. 31, no. 12, p. 1060, 2013. View at Google Scholar
  83. P. Jilma-Stohlawetz, J. C. Gilbert, M. E. Gorczyca, P. Knöbl, and B. Jilma, “A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombo-cytopenic purpura,” Thrombosis and Haemostasis, vol. 106, no. 3, pp. 539–547, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. A. D. Keefe, S. Pai, and A. Ellington, “Aptamers as therapeutics,” Nature Reviews Drug Discovery, vol. 9, no. 7, pp. 537–550, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. Nakamura, A. Ishiguro, and S. Miyakawa, “RNA plasticity and selectivity applicable to therapeutics and novel biosensor development,” Genes to Cells, vol. 17, no. 5, pp. 344–364, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. H. Akiyama, S. Kachi, R. L. E. Silva et al., “Intraocular injection of an aptamer that binds PDGF-B: a potential treatment for proliferative retinopathies,” Journal of Cellular Physiology, vol. 207, no. 2, pp. 407–412, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. M. N. Darisipudi, O. P. Kulkarni, S. G. Sayyed et al., “Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease,” The American Journal of Pathology, vol. 179, no. 1, pp. 116–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  88. F. Schwoebel, L. T. van Eijk, D. Zboralski et al., “The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys,” Blood, vol. 121, no. 12, pp. 2311–2315, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. L. A. Parunov, O. A. Fadeeva, A. N. Balandina et al., “Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation,” Journal of Thrombosis and Haemostasis, vol. 9, no. 9, pp. 1825–1834, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. C.-H. B. Chen, G. A. Chernis, V. Q. Hoang, and R. Landgraf, “Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 16, pp. 9226–9231, 2003. View at Publisher · View at Google Scholar · View at Scopus
  91. S. E. Lupold, B. J. Hicke, Y. Lin, and D. S. Coffey, “Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen,” Cancer Research, vol. 62, no. 14, pp. 4029–4033, 2002. View at Google Scholar · View at Scopus
  92. T. C. Chu, K. Y. Twu, A. D. Ellington, and M. Levy, “Aptamer mediated siRNA delivery,” Nucleic Acids Research, vol. 34, no. 10, article e73, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. X. Ni, Y. Zhang, J. Ribas et al., “Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts,” The Journal of Clinical Investigation, vol. 121, no. 6, pp. 2383–2390, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. J. Zhou, Y. Shu, P. Guo, D. D. Smith, and J. J. Rossi, “Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition,” Methods, vol. 54, no. 2, pp. 284–294, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. S. D. Seiwert, T. S. Nahreini, S. Aigner, N. G. Ahn, and O. C. Uhlenbeck, “RNA aptamers as pathway-specific MAP kinase inhibitors,” Chemistry & Biology, vol. 7, no. 11, pp. 833–843, 2000. View at Publisher · View at Google Scholar · View at Scopus
  96. A. D. Luster, R. Alon, and U. H. von Andrian, “Immune cell migration in inflammation: present and future therapeutic targets,” Nature Immunology, vol. 6, no. 12, pp. 1182–1190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. W. Zhao, W. Loh, I. A. Droujinine et al., “Mimicking the inflammatory cell adhesion cascade by nucleic acid aptamer programmed cell-cell interactions,” FASEB Journal, vol. 25, no. 9, pp. 3045–3056, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. D. Xu and H. Shi, “Composite RNA aptamers as functional mimics of proteins,” Nucleic Acids Research, vol. 37, no. 9, article e71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. J. S. Paige, K. Y. Wu, and S. R. Jaffrey, “RNA mimics of green fluorescent protein,” Science, vol. 333, no. 6042, pp. 642–646, 2011. View at Publisher · View at Google Scholar · View at Scopus